nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—CYP2B6—Colchicine—gout	0.0717	0.115	CbGbCtD
Paroxetine—CYP2C8—Naproxen—gout	0.0717	0.115	CbGbCtD
Paroxetine—CYP2C8—Colchicine—gout	0.0543	0.0869	CbGbCtD
Paroxetine—CYP2C9—Naproxen—gout	0.05	0.08	CbGbCtD
Paroxetine—CYP2C8—Probenecid—gout	0.0487	0.0778	CbGbCtD
Paroxetine—CYP2C9—Colchicine—gout	0.0379	0.0606	CbGbCtD
Paroxetine—ABCB1—Colchicine—gout	0.0368	0.0588	CbGbCtD
Paroxetine—CYP2C9—Probenecid—gout	0.0339	0.0543	CbGbCtD
Paroxetine—CYP2C9—Indomethacin—gout	0.033	0.0529	CbGbCtD
Paroxetine—ABCB1—Probenecid—gout	0.0329	0.0527	CbGbCtD
Paroxetine—ABCB1—Methylprednisolone—gout	0.0325	0.052	CbGbCtD
Paroxetine—ABCB1—Indomethacin—gout	0.0321	0.0513	CbGbCtD
Paroxetine—CYP2C8—Hydrocortisone—gout	0.0292	0.0467	CbGbCtD
Paroxetine—ABCB1—Prednisolone—gout	0.0208	0.0333	CbGbCtD
Paroxetine—ABCB1—Hydrocortisone—gout	0.0198	0.0316	CbGbCtD
Paroxetine—ABCB1—Prednisone—gout	0.0197	0.0315	CbGbCtD
Paroxetine—ABCB1—Abacavir transmembrane transport—ABCG2—gout	0.000607	0.0859	CbGpPWpGaD
Paroxetine—ABCB1—Abacavir transport and metabolism—ABCG2—gout	0.000349	0.0493	CbGpPWpGaD
Paroxetine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A11—gout	0.000348	0.0491	CbGpPWpGaD
Paroxetine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A11—gout	0.000308	0.0435	CbGpPWpGaD
Paroxetine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—gout	0.000263	0.0372	CbGpPWpGaD
Paroxetine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—gout	0.000245	0.0346	CbGpPWpGaD
Paroxetine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—gout	0.000233	0.033	CbGpPWpGaD
Paroxetine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—gout	0.000217	0.0307	CbGpPWpGaD
Paroxetine—SLC6A4—NRF2 pathway—SLC2A9—gout	0.000205	0.029	CbGpPWpGaD
Paroxetine—SLC6A2—NRF2 pathway—SLC2A9—gout	0.000177	0.025	CbGpPWpGaD
Paroxetine—TACR1—SIDS Susceptibility Pathways—IL1RN—gout	0.000167	0.0237	CbGpPWpGaD
Paroxetine—SLC6A2—SLC-mediated transmembrane transport—SLC17A1—gout	0.000158	0.0223	CbGpPWpGaD
Paroxetine—SLC6A2—SLC-mediated transmembrane transport—SLC22A11—gout	0.000158	0.0223	CbGpPWpGaD
Paroxetine—SLC6A3—NRF2 pathway—SLC2A9—gout	0.000156	0.0221	CbGpPWpGaD
Paroxetine—SLC6A3—SLC-mediated transmembrane transport—SLC17A1—gout	0.00014	0.0198	CbGpPWpGaD
Paroxetine—SLC6A3—SLC-mediated transmembrane transport—SLC22A11—gout	0.00014	0.0198	CbGpPWpGaD
Paroxetine—Abdominal pain—Naproxen—gout	0.000127	0.000346	CcSEcCtD
Paroxetine—Body temperature increased—Naproxen—gout	0.000127	0.000346	CcSEcCtD
Paroxetine—Nausea—Colchicine—gout	0.000127	0.000345	CcSEcCtD
Paroxetine—Osteoarthritis—Prednisone—gout	0.000126	0.000343	CcSEcCtD
Paroxetine—Gastrointestinal haemorrhage—Prednisone—gout	0.000126	0.000343	CcSEcCtD
Paroxetine—Diarrhoea—Allopurinol—gout	0.000126	0.000343	CcSEcCtD
Paroxetine—Weight increased—Methylprednisolone—gout	0.000125	0.000341	CcSEcCtD
Paroxetine—Affect lability—Prednisone—gout	0.000124	0.000338	CcSEcCtD
Paroxetine—Psychotic disorder—Prednisone—gout	0.000123	0.000335	CcSEcCtD
Paroxetine—Bradycardia—Prednisolone—gout	0.000122	0.000333	CcSEcCtD
Paroxetine—Face oedema—Prednisone—gout	0.000122	0.000331	CcSEcCtD
Paroxetine—Dizziness—Allopurinol—gout	0.000122	0.000331	CcSEcCtD
Paroxetine—Acute coronary syndrome—Methylprednisolone—gout	0.000121	0.000329	CcSEcCtD
Paroxetine—Haemoglobin—Prednisolone—gout	0.000121	0.000328	CcSEcCtD
Paroxetine—Nausea—Indomethacin—gout	0.000121	0.000328	CcSEcCtD
Paroxetine—Neuropathy peripheral—Methylprednisolone—gout	0.00012	0.000327	CcSEcCtD
Paroxetine—Myocardial infarction—Methylprednisolone—gout	0.00012	0.000327	CcSEcCtD
Paroxetine—Haemorrhage—Prednisolone—gout	0.00012	0.000327	CcSEcCtD
Paroxetine—SLC6A2—SLC-mediated transmembrane transport—SLC22A12—gout	0.00012	0.0169	CbGpPWpGaD
Paroxetine—Mood swings—Prednisone—gout	0.00012	0.000325	CcSEcCtD
Paroxetine—Bradycardia—Hydrocortisone—gout	0.00012	0.000325	CcSEcCtD
Paroxetine—Hypersensitivity—Naproxen—gout	0.000118	0.000322	CcSEcCtD
Paroxetine—Haemoglobin—Hydrocortisone—gout	0.000118	0.000321	CcSEcCtD
Paroxetine—Sweating—Methylprednisolone—gout	0.000118	0.00032	CcSEcCtD
Paroxetine—Haemorrhage—Hydrocortisone—gout	0.000117	0.000319	CcSEcCtD
Paroxetine—Vomiting—Allopurinol—gout	0.000117	0.000318	CcSEcCtD
Paroxetine—Hallucination—Hydrocortisone—gout	0.000117	0.000318	CcSEcCtD
Paroxetine—Rash—Allopurinol—gout	0.000116	0.000316	CcSEcCtD
Paroxetine—Dermatitis—Allopurinol—gout	0.000116	0.000315	CcSEcCtD
Paroxetine—Visual impairment—Prednisolone—gout	0.000116	0.000315	CcSEcCtD
Paroxetine—Dry skin—Prednisone—gout	0.000116	0.000315	CcSEcCtD
Paroxetine—Headache—Allopurinol—gout	0.000115	0.000314	CcSEcCtD
Paroxetine—Asthenia—Naproxen—gout	0.000115	0.000314	CcSEcCtD
Paroxetine—Connective tissue disorder—Hydrocortisone—gout	0.000115	0.000314	CcSEcCtD
Paroxetine—Hypokalaemia—Prednisone—gout	0.000115	0.000312	CcSEcCtD
Paroxetine—Pruritus—Naproxen—gout	0.000114	0.000309	CcSEcCtD
Paroxetine—Bradycardia—Methylprednisolone—gout	0.000112	0.000305	CcSEcCtD
Paroxetine—Alanine aminotransferase increased—Prednisone—gout	0.000111	0.000303	CcSEcCtD
Paroxetine—Muscular weakness—Prednisone—gout	0.000111	0.000303	CcSEcCtD
Paroxetine—SLC6A2—SLC-mediated transmembrane transport—SLC2A9—gout	0.000111	0.0157	CbGpPWpGaD
Paroxetine—Haemoglobin—Methylprednisolone—gout	0.000111	0.000301	CcSEcCtD
Paroxetine—Rhinitis—Methylprednisolone—gout	0.000111	0.000301	CcSEcCtD
Paroxetine—Haemorrhage—Methylprednisolone—gout	0.00011	0.0003	CcSEcCtD
Paroxetine—Diarrhoea—Naproxen—gout	0.00011	0.000299	CcSEcCtD
Paroxetine—Hallucination—Methylprednisolone—gout	0.00011	0.000298	CcSEcCtD
Paroxetine—Eye disorder—Hydrocortisone—gout	0.00011	0.000298	CcSEcCtD
Paroxetine—Nausea—Allopurinol—gout	0.000109	0.000297	CcSEcCtD
Paroxetine—Connective tissue disorder—Methylprednisolone—gout	0.000108	0.000295	CcSEcCtD
Paroxetine—Arrhythmia—Prednisolone—gout	0.000107	0.000292	CcSEcCtD
Paroxetine—Pancreatitis—Prednisone—gout	0.000107	0.000291	CcSEcCtD
Paroxetine—Dizziness—Naproxen—gout	0.000106	0.000289	CcSEcCtD
Paroxetine—Sweating increased—Prednisone—gout	0.000106	0.000289	CcSEcCtD
Paroxetine—Visual impairment—Methylprednisolone—gout	0.000106	0.000289	CcSEcCtD
Paroxetine—SLC6A3—SLC-mediated transmembrane transport—SLC22A12—gout	0.000106	0.015	CbGpPWpGaD
Paroxetine—Immune system disorder—Hydrocortisone—gout	0.000106	0.000288	CcSEcCtD
Paroxetine—Arrhythmia—Hydrocortisone—gout	0.000105	0.000285	CcSEcCtD
Paroxetine—Erythema—Prednisolone—gout	0.000105	0.000284	CcSEcCtD
Paroxetine—Eye disorder—Methylprednisolone—gout	0.000103	0.00028	CcSEcCtD
Paroxetine—Mental disorder—Hydrocortisone—gout	0.000103	0.00028	CcSEcCtD
Paroxetine—Cardiac disorder—Methylprednisolone—gout	0.000102	0.000278	CcSEcCtD
Paroxetine—Vomiting—Naproxen—gout	0.000102	0.000278	CcSEcCtD
Paroxetine—Malnutrition—Hydrocortisone—gout	0.000102	0.000278	CcSEcCtD
Paroxetine—Erythema—Hydrocortisone—gout	0.000102	0.000278	CcSEcCtD
Paroxetine—Rash—Naproxen—gout	0.000101	0.000276	CcSEcCtD
Paroxetine—Dermatitis—Naproxen—gout	0.000101	0.000275	CcSEcCtD
Paroxetine—Headache—Naproxen—gout	0.000101	0.000274	CcSEcCtD
Paroxetine—Erectile dysfunction—Prednisone—gout	0.000101	0.000273	CcSEcCtD
Paroxetine—Angiopathy—Methylprednisolone—gout	0.0001	0.000272	CcSEcCtD
Paroxetine—Immune system disorder—Methylprednisolone—gout	9.96e-05	0.000271	CcSEcCtD
Paroxetine—Mediastinal disorder—Methylprednisolone—gout	9.94e-05	0.00027	CcSEcCtD
Paroxetine—Weight increased—Prednisone—gout	9.93e-05	0.00027	CcSEcCtD
Paroxetine—Weight decreased—Prednisone—gout	9.87e-05	0.000268	CcSEcCtD
Paroxetine—Vision blurred—Prednisolone—gout	9.86e-05	0.000268	CcSEcCtD
Paroxetine—SLC6A3—SLC-mediated transmembrane transport—SLC2A9—gout	9.86e-05	0.0139	CbGpPWpGaD
Paroxetine—Arrhythmia—Methylprednisolone—gout	9.85e-05	0.000268	CcSEcCtD
Paroxetine—SLC6A2—Transmembrane transport of small molecules—SLC17A3—gout	9.85e-05	0.0139	CbGpPWpGaD
Paroxetine—Hyperglycaemia—Prednisone—gout	9.84e-05	0.000268	CcSEcCtD
Paroxetine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	9.78e-05	0.0138	CbGpPWpGaD
Paroxetine—Ill-defined disorder—Prednisolone—gout	9.71e-05	0.000264	CcSEcCtD
Paroxetine—Depression—Prednisone—gout	9.7e-05	0.000264	CcSEcCtD
Paroxetine—Mental disorder—Methylprednisolone—gout	9.66e-05	0.000263	CcSEcCtD
Paroxetine—Erythema—Methylprednisolone—gout	9.6e-05	0.000261	CcSEcCtD
Paroxetine—Malnutrition—Methylprednisolone—gout	9.6e-05	0.000261	CcSEcCtD
Paroxetine—Acute coronary syndrome—Prednisone—gout	9.59e-05	0.000261	CcSEcCtD
Paroxetine—Angioedema—Prednisolone—gout	9.56e-05	0.00026	CcSEcCtD
Paroxetine—Nausea—Naproxen—gout	9.55e-05	0.00026	CcSEcCtD
Paroxetine—Myocardial infarction—Prednisone—gout	9.54e-05	0.000259	CcSEcCtD
Paroxetine—Neuropathy peripheral—Prednisone—gout	9.54e-05	0.000259	CcSEcCtD
Paroxetine—Ill-defined disorder—Hydrocortisone—gout	9.48e-05	0.000258	CcSEcCtD
Paroxetine—Malaise—Prednisolone—gout	9.44e-05	0.000257	CcSEcCtD
Paroxetine—Vertigo—Prednisolone—gout	9.4e-05	0.000256	CcSEcCtD
Paroxetine—Syncope—Prednisolone—gout	9.38e-05	0.000255	CcSEcCtD
Paroxetine—Angioedema—Hydrocortisone—gout	9.34e-05	0.000254	CcSEcCtD
Paroxetine—Malaise—Hydrocortisone—gout	9.22e-05	0.000251	CcSEcCtD
Paroxetine—Loss of consciousness—Prednisolone—gout	9.2e-05	0.00025	CcSEcCtD
Paroxetine—Vertigo—Hydrocortisone—gout	9.18e-05	0.00025	CcSEcCtD
Paroxetine—Syncope—Hydrocortisone—gout	9.16e-05	0.000249	CcSEcCtD
Paroxetine—Convulsion—Prednisolone—gout	9.07e-05	0.000246	CcSEcCtD
Paroxetine—Hypertension—Prednisolone—gout	9.03e-05	0.000246	CcSEcCtD
Paroxetine—Loss of consciousness—Hydrocortisone—gout	8.98e-05	0.000244	CcSEcCtD
Paroxetine—Ill-defined disorder—Methylprednisolone—gout	8.91e-05	0.000242	CcSEcCtD
Paroxetine—Bradycardia—Prednisone—gout	8.89e-05	0.000242	CcSEcCtD
Paroxetine—Convulsion—Hydrocortisone—gout	8.85e-05	0.000241	CcSEcCtD
Paroxetine—Hypertension—Hydrocortisone—gout	8.82e-05	0.00024	CcSEcCtD
Paroxetine—Discomfort—Prednisolone—gout	8.8e-05	0.000239	CcSEcCtD
Paroxetine—Haemoglobin—Prednisone—gout	8.78e-05	0.000239	CcSEcCtD
Paroxetine—Angioedema—Methylprednisolone—gout	8.77e-05	0.000239	CcSEcCtD
Paroxetine—Haemorrhage—Prednisone—gout	8.73e-05	0.000237	CcSEcCtD
Paroxetine—SLC6A3—Transmembrane transport of small molecules—SLC17A3—gout	8.72e-05	0.0123	CbGpPWpGaD
Paroxetine—Myalgia—Hydrocortisone—gout	8.7e-05	0.000237	CcSEcCtD
Paroxetine—Hallucination—Prednisone—gout	8.69e-05	0.000236	CcSEcCtD
Paroxetine—Anxiety—Hydrocortisone—gout	8.67e-05	0.000236	CcSEcCtD
Paroxetine—SLC6A4—SIDS Susceptibility Pathways—IL1RN—gout	8.66e-05	0.0122	CbGpPWpGaD
Paroxetine—Malaise—Methylprednisolone—gout	8.66e-05	0.000235	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—gout	8.64e-05	0.000235	CcSEcCtD
Paroxetine—Vertigo—Methylprednisolone—gout	8.63e-05	0.000235	CcSEcCtD
Paroxetine—Syncope—Methylprednisolone—gout	8.61e-05	0.000234	CcSEcCtD
Paroxetine—Discomfort—Hydrocortisone—gout	8.6e-05	0.000234	CcSEcCtD
Paroxetine—Connective tissue disorder—Prednisone—gout	8.58e-05	0.000233	CcSEcCtD
Paroxetine—Oedema—Prednisolone—gout	8.54e-05	0.000232	CcSEcCtD
Paroxetine—Anaphylactic shock—Prednisolone—gout	8.54e-05	0.000232	CcSEcCtD
Paroxetine—Loss of consciousness—Methylprednisolone—gout	8.44e-05	0.000229	CcSEcCtD
Paroxetine—Shock—Prednisolone—gout	8.4e-05	0.000228	CcSEcCtD
Paroxetine—Anaphylactic shock—Hydrocortisone—gout	8.34e-05	0.000227	CcSEcCtD
Paroxetine—Oedema—Hydrocortisone—gout	8.34e-05	0.000227	CcSEcCtD
Paroxetine—Tachycardia—Prednisolone—gout	8.33e-05	0.000227	CcSEcCtD
Paroxetine—Convulsion—Methylprednisolone—gout	8.32e-05	0.000226	CcSEcCtD
Paroxetine—Hypertension—Methylprednisolone—gout	8.29e-05	0.000225	CcSEcCtD
Paroxetine—Infection—Hydrocortisone—gout	8.29e-05	0.000225	CcSEcCtD
Paroxetine—Hyperhidrosis—Prednisolone—gout	8.26e-05	0.000224	CcSEcCtD
Paroxetine—Shock—Hydrocortisone—gout	8.21e-05	0.000223	CcSEcCtD
Paroxetine—Nervous system disorder—Hydrocortisone—gout	8.18e-05	0.000222	CcSEcCtD
Paroxetine—Myalgia—Methylprednisolone—gout	8.17e-05	0.000222	CcSEcCtD
Paroxetine—Arthralgia—Methylprednisolone—gout	8.17e-05	0.000222	CcSEcCtD
Paroxetine—Eye disorder—Prednisone—gout	8.16e-05	0.000222	CcSEcCtD
Paroxetine—Anxiety—Methylprednisolone—gout	8.15e-05	0.000221	CcSEcCtD
Paroxetine—Tachycardia—Hydrocortisone—gout	8.14e-05	0.000221	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—gout	8.12e-05	0.000221	CcSEcCtD
Paroxetine—Flushing—Prednisone—gout	8.11e-05	0.00022	CcSEcCtD
Paroxetine—Skin disorder—Hydrocortisone—gout	8.1e-05	0.00022	CcSEcCtD
Paroxetine—Discomfort—Methylprednisolone—gout	8.08e-05	0.00022	CcSEcCtD
Paroxetine—Hyperhidrosis—Hydrocortisone—gout	8.06e-05	0.000219	CcSEcCtD
Paroxetine—SLC6A2—Transmembrane transport of small molecules—SLC22A11—gout	8.03e-05	0.0113	CbGpPWpGaD
Paroxetine—SLC6A2—Transmembrane transport of small molecules—SLC17A1—gout	8.03e-05	0.0113	CbGpPWpGaD
Paroxetine—Angiopathy—Prednisone—gout	7.92e-05	0.000215	CcSEcCtD
Paroxetine—Confusional state—Methylprednisolone—gout	7.9e-05	0.000215	CcSEcCtD
Paroxetine—Immune system disorder—Prednisone—gout	7.89e-05	0.000214	CcSEcCtD
Paroxetine—Anaphylactic shock—Methylprednisolone—gout	7.84e-05	0.000213	CcSEcCtD
Paroxetine—Arrhythmia—Prednisone—gout	7.8e-05	0.000212	CcSEcCtD
Paroxetine—Hypotension—Hydrocortisone—gout	7.79e-05	0.000212	CcSEcCtD
Paroxetine—Infection—Methylprednisolone—gout	7.78e-05	0.000212	CcSEcCtD
Paroxetine—Insomnia—Prednisolone—gout	7.72e-05	0.00021	CcSEcCtD
Paroxetine—Alopecia—Prednisone—gout	7.72e-05	0.00021	CcSEcCtD
Paroxetine—Shock—Methylprednisolone—gout	7.71e-05	0.00021	CcSEcCtD
Paroxetine—ABCB1—HIF-1-alpha transcription factor network—ABCG2—gout	7.71e-05	0.0109	CbGpPWpGaD
Paroxetine—Nervous system disorder—Methylprednisolone—gout	7.68e-05	0.000209	CcSEcCtD
Paroxetine—Paraesthesia—Prednisolone—gout	7.67e-05	0.000208	CcSEcCtD
Paroxetine—Mental disorder—Prednisone—gout	7.65e-05	0.000208	CcSEcCtD
Paroxetine—Tachycardia—Methylprednisolone—gout	7.65e-05	0.000208	CcSEcCtD
Paroxetine—Skin disorder—Methylprednisolone—gout	7.61e-05	0.000207	CcSEcCtD
Paroxetine—Erythema—Prednisone—gout	7.6e-05	0.000207	CcSEcCtD
Paroxetine—Malnutrition—Prednisone—gout	7.6e-05	0.000207	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Hydrocortisone—gout	7.6e-05	0.000207	CcSEcCtD
Paroxetine—Hyperhidrosis—Methylprednisolone—gout	7.57e-05	0.000206	CcSEcCtD
Paroxetine—Insomnia—Hydrocortisone—gout	7.54e-05	0.000205	CcSEcCtD
Paroxetine—Paraesthesia—Hydrocortisone—gout	7.49e-05	0.000204	CcSEcCtD
Paroxetine—Dyspepsia—Hydrocortisone—gout	7.34e-05	0.0002	CcSEcCtD
Paroxetine—Hypotension—Methylprednisolone—gout	7.32e-05	0.000199	CcSEcCtD
Paroxetine—Pain—Prednisolone—gout	7.3e-05	0.000199	CcSEcCtD
Paroxetine—Decreased appetite—Hydrocortisone—gout	7.25e-05	0.000197	CcSEcCtD
Paroxetine—TACR1—Peptide ligand-binding receptors—POMC—gout	7.23e-05	0.0102	CbGpPWpGaD
Paroxetine—Gastrointestinal disorder—Hydrocortisone—gout	7.2e-05	0.000196	CcSEcCtD
Paroxetine—Fatigue—Hydrocortisone—gout	7.19e-05	0.000195	CcSEcCtD
Paroxetine—Vision blurred—Prednisone—gout	7.17e-05	0.000195	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Methylprednisolone—gout	7.14e-05	0.000194	CcSEcCtD
Paroxetine—Pain—Hydrocortisone—gout	7.13e-05	0.000194	CcSEcCtD
Paroxetine—SLC6A3—Transmembrane transport of small molecules—SLC22A11—gout	7.11e-05	0.0101	CbGpPWpGaD
Paroxetine—SLC6A3—Transmembrane transport of small molecules—SLC17A1—gout	7.11e-05	0.0101	CbGpPWpGaD
Paroxetine—Insomnia—Methylprednisolone—gout	7.09e-05	0.000193	CcSEcCtD
Paroxetine—Ill-defined disorder—Prednisone—gout	7.05e-05	0.000192	CcSEcCtD
Paroxetine—Feeling abnormal—Prednisolone—gout	7.04e-05	0.000191	CcSEcCtD
Paroxetine—Paraesthesia—Methylprednisolone—gout	7.04e-05	0.000191	CcSEcCtD
Paroxetine—Anaemia—Prednisone—gout	7.03e-05	0.000191	CcSEcCtD
Paroxetine—Agitation—Prednisone—gout	6.99e-05	0.00019	CcSEcCtD
Paroxetine—Angioedema—Prednisone—gout	6.95e-05	0.000189	CcSEcCtD
Paroxetine—Dyspepsia—Methylprednisolone—gout	6.9e-05	0.000188	CcSEcCtD
Paroxetine—Feeling abnormal—Hydrocortisone—gout	6.87e-05	0.000187	CcSEcCtD
Paroxetine—Malaise—Prednisone—gout	6.86e-05	0.000186	CcSEcCtD
Paroxetine—Vertigo—Prednisone—gout	6.83e-05	0.000186	CcSEcCtD
Paroxetine—Gastrointestinal pain—Hydrocortisone—gout	6.82e-05	0.000185	CcSEcCtD
Paroxetine—Syncope—Prednisone—gout	6.82e-05	0.000185	CcSEcCtD
Paroxetine—Urticaria—Prednisolone—gout	6.78e-05	0.000184	CcSEcCtD
Paroxetine—Fatigue—Methylprednisolone—gout	6.76e-05	0.000184	CcSEcCtD
Paroxetine—Loss of consciousness—Prednisone—gout	6.68e-05	0.000182	CcSEcCtD
Paroxetine—Urticaria—Hydrocortisone—gout	6.63e-05	0.00018	CcSEcCtD
Paroxetine—Abdominal pain—Hydrocortisone—gout	6.59e-05	0.000179	CcSEcCtD
Paroxetine—Body temperature increased—Hydrocortisone—gout	6.59e-05	0.000179	CcSEcCtD
Paroxetine—Convulsion—Prednisone—gout	6.59e-05	0.000179	CcSEcCtD
Paroxetine—Hypertension—Prednisone—gout	6.56e-05	0.000178	CcSEcCtD
Paroxetine—Arthralgia—Prednisone—gout	6.47e-05	0.000176	CcSEcCtD
Paroxetine—Myalgia—Prednisone—gout	6.47e-05	0.000176	CcSEcCtD
Paroxetine—Feeling abnormal—Methylprednisolone—gout	6.46e-05	0.000176	CcSEcCtD
Paroxetine—Anxiety—Prednisone—gout	6.45e-05	0.000175	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—gout	6.43e-05	0.000175	CcSEcCtD
Paroxetine—Gastrointestinal pain—Methylprednisolone—gout	6.41e-05	0.000174	CcSEcCtD
Paroxetine—Discomfort—Prednisone—gout	6.4e-05	0.000174	CcSEcCtD
Paroxetine—Hypersensitivity—Prednisolone—gout	6.29e-05	0.000171	CcSEcCtD
Paroxetine—Urticaria—Methylprednisolone—gout	6.22e-05	0.000169	CcSEcCtD
Paroxetine—Oedema—Prednisone—gout	6.21e-05	0.000169	CcSEcCtD
Paroxetine—Anaphylactic shock—Prednisone—gout	6.21e-05	0.000169	CcSEcCtD
Paroxetine—Abdominal pain—Methylprednisolone—gout	6.19e-05	0.000168	CcSEcCtD
Paroxetine—Infection—Prednisone—gout	6.16e-05	0.000168	CcSEcCtD
Paroxetine—Hypersensitivity—Hydrocortisone—gout	6.14e-05	0.000167	CcSEcCtD
Paroxetine—Shock—Prednisone—gout	6.11e-05	0.000166	CcSEcCtD
Paroxetine—Nervous system disorder—Prednisone—gout	6.09e-05	0.000165	CcSEcCtD
Paroxetine—SLC6A2—Transmembrane transport of small molecules—SLC22A12—gout	6.08e-05	0.0086	CbGpPWpGaD
Paroxetine—Tachycardia—Prednisone—gout	6.06e-05	0.000165	CcSEcCtD
Paroxetine—Skin disorder—Prednisone—gout	6.03e-05	0.000164	CcSEcCtD
Paroxetine—Hyperhidrosis—Prednisone—gout	6e-05	0.000163	CcSEcCtD
Paroxetine—Asthenia—Hydrocortisone—gout	5.98e-05	0.000163	CcSEcCtD
Paroxetine—Pruritus—Hydrocortisone—gout	5.9e-05	0.00016	CcSEcCtD
Paroxetine—Hypersensitivity—Methylprednisolone—gout	5.77e-05	0.000157	CcSEcCtD
Paroxetine—Diarrhoea—Hydrocortisone—gout	5.71e-05	0.000155	CcSEcCtD
Paroxetine—SLC6A2—Transmembrane transport of small molecules—SLC2A9—gout	5.65e-05	0.00799	CbGpPWpGaD
Paroxetine—Musculoskeletal discomfort—Prednisone—gout	5.65e-05	0.000154	CcSEcCtD
Paroxetine—Dizziness—Prednisolone—gout	5.65e-05	0.000154	CcSEcCtD
Paroxetine—Asthenia—Methylprednisolone—gout	5.62e-05	0.000153	CcSEcCtD
Paroxetine—Insomnia—Prednisone—gout	5.61e-05	0.000153	CcSEcCtD
Paroxetine—Paraesthesia—Prednisone—gout	5.57e-05	0.000151	CcSEcCtD
Paroxetine—Pruritus—Methylprednisolone—gout	5.54e-05	0.000151	CcSEcCtD
Paroxetine—Dizziness—Hydrocortisone—gout	5.52e-05	0.00015	CcSEcCtD
Paroxetine—Dyspepsia—Prednisone—gout	5.46e-05	0.000149	CcSEcCtD
Paroxetine—Decreased appetite—Prednisone—gout	5.39e-05	0.000147	CcSEcCtD
Paroxetine—SLC6A3—Transmembrane transport of small molecules—SLC22A12—gout	5.39e-05	0.00762	CbGpPWpGaD
Paroxetine—Rash—Prednisolone—gout	5.38e-05	0.000146	CcSEcCtD
Paroxetine—Dermatitis—Prednisolone—gout	5.38e-05	0.000146	CcSEcCtD
Paroxetine—Diarrhoea—Methylprednisolone—gout	5.36e-05	0.000146	CcSEcCtD
Paroxetine—Fatigue—Prednisone—gout	5.35e-05	0.000145	CcSEcCtD
Paroxetine—Headache—Prednisolone—gout	5.35e-05	0.000145	CcSEcCtD
Paroxetine—Constipation—Prednisone—gout	5.31e-05	0.000144	CcSEcCtD
Paroxetine—Vomiting—Hydrocortisone—gout	5.3e-05	0.000144	CcSEcCtD
Paroxetine—Rash—Hydrocortisone—gout	5.26e-05	0.000143	CcSEcCtD
Paroxetine—Dermatitis—Hydrocortisone—gout	5.25e-05	0.000143	CcSEcCtD
Paroxetine—Headache—Hydrocortisone—gout	5.22e-05	0.000142	CcSEcCtD
Paroxetine—HTR2A—SIDS Susceptibility Pathways—IL1RN—gout	5.21e-05	0.00737	CbGpPWpGaD
Paroxetine—Dizziness—Methylprednisolone—gout	5.18e-05	0.000141	CcSEcCtD
Paroxetine—CHRM2—SIDS Susceptibility Pathways—IL1RN—gout	5.12e-05	0.00724	CbGpPWpGaD
Paroxetine—Feeling abnormal—Prednisone—gout	5.11e-05	0.000139	CcSEcCtD
Paroxetine—Gastrointestinal pain—Prednisone—gout	5.07e-05	0.000138	CcSEcCtD
Paroxetine—Nausea—Prednisolone—gout	5.07e-05	0.000138	CcSEcCtD
Paroxetine—SLC6A3—Transmembrane transport of small molecules—SLC2A9—gout	5.01e-05	0.00708	CbGpPWpGaD
Paroxetine—Vomiting—Methylprednisolone—gout	4.98e-05	0.000135	CcSEcCtD
Paroxetine—Nausea—Hydrocortisone—gout	4.95e-05	0.000135	CcSEcCtD
Paroxetine—Rash—Methylprednisolone—gout	4.94e-05	0.000134	CcSEcCtD
Paroxetine—Dermatitis—Methylprednisolone—gout	4.94e-05	0.000134	CcSEcCtD
Paroxetine—Urticaria—Prednisone—gout	4.93e-05	0.000134	CcSEcCtD
Paroxetine—Headache—Methylprednisolone—gout	4.91e-05	0.000133	CcSEcCtD
Paroxetine—Body temperature increased—Prednisone—gout	4.91e-05	0.000133	CcSEcCtD
Paroxetine—Abdominal pain—Prednisone—gout	4.91e-05	0.000133	CcSEcCtD
Paroxetine—TACR1—Class A/1 (Rhodopsin-like receptors)—POMC—gout	4.85e-05	0.00686	CbGpPWpGaD
Paroxetine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—gout	4.83e-05	0.00683	CbGpPWpGaD
Paroxetine—Nausea—Methylprednisolone—gout	4.65e-05	0.000127	CcSEcCtD
Paroxetine—Hypersensitivity—Prednisone—gout	4.57e-05	0.000124	CcSEcCtD
Paroxetine—Asthenia—Prednisone—gout	4.45e-05	0.000121	CcSEcCtD
Paroxetine—Pruritus—Prednisone—gout	4.39e-05	0.000119	CcSEcCtD
Paroxetine—ABCB1—Transmembrane transport of small molecules—SLC17A3—gout	4.34e-05	0.00613	CbGpPWpGaD
Paroxetine—Diarrhoea—Prednisone—gout	4.25e-05	0.000115	CcSEcCtD
Paroxetine—Dizziness—Prednisone—gout	4.1e-05	0.000112	CcSEcCtD
Paroxetine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—gout	4.09e-05	0.00578	CbGpPWpGaD
Paroxetine—Vomiting—Prednisone—gout	3.95e-05	0.000107	CcSEcCtD
Paroxetine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—gout	3.92e-05	0.00554	CbGpPWpGaD
Paroxetine—Rash—Prednisone—gout	3.91e-05	0.000106	CcSEcCtD
Paroxetine—Dermatitis—Prednisone—gout	3.91e-05	0.000106	CcSEcCtD
Paroxetine—Headache—Prednisone—gout	3.89e-05	0.000106	CcSEcCtD
Paroxetine—TACR1—GPCR ligand binding—POMC—gout	3.7e-05	0.00522	CbGpPWpGaD
Paroxetine—Nausea—Prednisone—gout	3.69e-05	0.0001	CcSEcCtD
Paroxetine—ABCB1—Transmembrane transport of small molecules—SLC22A11—gout	3.53e-05	0.005	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—SLC17A1—gout	3.53e-05	0.005	CbGpPWpGaD
Paroxetine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—gout	3.36e-05	0.00475	CbGpPWpGaD
Paroxetine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—gout	3.33e-05	0.00471	CbGpPWpGaD
Paroxetine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—gout	3.31e-05	0.00469	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—BCKDHA—gout	3.2e-05	0.00452	CbGpPWpGaD
Paroxetine—SLC6A2—Transmembrane transport of small molecules—ABCG2—gout	2.97e-05	0.0042	CbGpPWpGaD
Paroxetine—CHRM4—G alpha (i) signalling events—POMC—gout	2.8e-05	0.00396	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—BCKDHA—gout	2.75e-05	0.00389	CbGpPWpGaD
Paroxetine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—gout	2.72e-05	0.00385	CbGpPWpGaD
Paroxetine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—gout	2.7e-05	0.00381	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—SLC22A12—gout	2.68e-05	0.00379	CbGpPWpGaD
Paroxetine—SLC6A3—Transmembrane transport of small molecules—ABCG2—gout	2.63e-05	0.00372	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PRPS1—gout	2.61e-05	0.00369	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PRPS2—gout	2.61e-05	0.00369	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—HPRT1—gout	2.61e-05	0.00369	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—SLC2A9—gout	2.49e-05	0.00352	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—BCKDHA—gout	2.33e-05	0.0033	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PRPS2—gout	2.24e-05	0.00317	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PRPS1—gout	2.24e-05	0.00317	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—HPRT1—gout	2.24e-05	0.00317	CbGpPWpGaD
Paroxetine—CHRM4—Class A/1 (Rhodopsin-like receptors)—POMC—gout	2.23e-05	0.00315	CbGpPWpGaD
Paroxetine—CHRM5—Class A/1 (Rhodopsin-like receptors)—POMC—gout	2.13e-05	0.00302	CbGpPWpGaD
Paroxetine—TACR1—GPCR downstream signaling—POMC—gout	2.09e-05	0.00295	CbGpPWpGaD
Paroxetine—CYP2B6—Biological oxidations—POMC—gout	2.08e-05	0.00294	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—BCKDHA—gout	2.03e-05	0.00287	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—BCKDHA—gout	1.91e-05	0.00271	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PRPS1—gout	1.9e-05	0.00269	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—HPRT1—gout	1.9e-05	0.00269	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PRPS2—gout	1.9e-05	0.00269	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—BCKDHA—gout	1.9e-05	0.00268	CbGpPWpGaD
Paroxetine—TACR1—Signaling by GPCR—POMC—gout	1.9e-05	0.00268	CbGpPWpGaD
Paroxetine—CHRM2—G alpha (i) signalling events—POMC—gout	1.87e-05	0.00264	CbGpPWpGaD
Paroxetine—CYP2C8—Biological oxidations—POMC—gout	1.76e-05	0.00249	CbGpPWpGaD
Paroxetine—CHRM4—GPCR ligand binding—POMC—gout	1.7e-05	0.0024	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—HPRT1—gout	1.66e-05	0.00234	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PRPS2—gout	1.66e-05	0.00234	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PRPS1—gout	1.66e-05	0.00234	CbGpPWpGaD
Paroxetine—CHRM5—GPCR ligand binding—POMC—gout	1.62e-05	0.0023	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—HPRT1—gout	1.56e-05	0.00221	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PRPS2—gout	1.56e-05	0.00221	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PRPS1—gout	1.56e-05	0.00221	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PRPS1—gout	1.55e-05	0.00219	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—HPRT1—gout	1.55e-05	0.00219	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PRPS2—gout	1.55e-05	0.00219	CbGpPWpGaD
Paroxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—gout	1.51e-05	0.00214	CbGpPWpGaD
Paroxetine—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—gout	1.5e-05	0.00212	CbGpPWpGaD
Paroxetine—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—gout	1.5e-05	0.00212	CbGpPWpGaD
Paroxetine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—gout	1.48e-05	0.0021	CbGpPWpGaD
Paroxetine—CYP2D6—Biological oxidations—POMC—gout	1.45e-05	0.00204	CbGpPWpGaD
Paroxetine—CYP2C9—Biological oxidations—POMC—gout	1.43e-05	0.00203	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—ABCG2—gout	1.31e-05	0.00185	CbGpPWpGaD
Paroxetine—HTR2A—GPCR ligand binding—POMC—gout	1.15e-05	0.00163	CbGpPWpGaD
Paroxetine—CHRM1—GPCR ligand binding—POMC—gout	1.14e-05	0.00162	CbGpPWpGaD
Paroxetine—CHRM3—GPCR ligand binding—POMC—gout	1.14e-05	0.00161	CbGpPWpGaD
Paroxetine—CHRM2—GPCR ligand binding—POMC—gout	1.13e-05	0.0016	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—POMC—gout	1.12e-05	0.00158	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—ABCG2—gout	9.66e-06	0.00137	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—POMC—gout	9.59e-06	0.00136	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—POMC—gout	9.18e-06	0.0013	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—POMC—gout	8.71e-06	0.00123	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—POMC—gout	8.34e-06	0.00118	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—ABCG2—gout	8.31e-06	0.00117	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ABCG2—gout	7.03e-06	0.000994	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—gout	6.76e-06	0.000956	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—POMC—gout	6.5e-06	0.000919	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—POMC—gout	6.47e-06	0.000914	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—POMC—gout	6.44e-06	0.000911	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—POMC—gout	6.38e-06	0.000902	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ABCG2—gout	6.13e-06	0.000866	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—POMC—gout	5.9e-06	0.000835	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—POMC—gout	5.87e-06	0.00083	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—POMC—gout	5.85e-06	0.000827	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—POMC—gout	5.8e-06	0.000819	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ABCG2—gout	5.77e-06	0.000816	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ABCG2—gout	5.72e-06	0.000809	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—gout	5.5e-06	0.000778	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—POMC—gout	5.14e-06	0.000727	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—POMC—gout	4.93e-06	0.000696	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—POMC—gout	4.13e-06	0.000585	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—POMC—gout	3.56e-06	0.000503	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—POMC—gout	3.49e-06	0.000493	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—POMC—gout	3.47e-06	0.00049	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—POMC—gout	3.46e-06	0.000489	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—POMC—gout	3.42e-06	0.000484	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—POMC—gout	3.01e-06	0.000426	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—POMC—gout	2.62e-06	0.000371	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—POMC—gout	2.47e-06	0.00035	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—POMC—gout	2.45e-06	0.000346	CbGpPWpGaD
